Three
Pilot and Feasibility grants will be awarded
in
2008
for basic or clinical research
in the fields of type-1 diabetes, type-2
diabetes
or their complications. Investigators either
at Joslin Diabetes Center or at institutions
within Harvard Medical School and affiliated
hospitals are eligible. The Principal
Investigator
must be a junior researcher who has not
yet received significant NIH or other
funding
(eg RO1 or equivalent), or a senior researcher
entering the diabetes field for the first
time or exploring a completely new direction.
For the first time, one of this year's three P&F awards will be a new type of grant designed to encourage translational research. Funded by the Joslin Diabetes Center Research Division, the grant will support a new collaborative project between a PI who is a basic scientist and a PI who is a clinician or clinical scientist. The project must focus on patients or patient samples -- studies on mice or other model systems are not eligible for this particular P&F award. At least one of the two collaborating PIs must be from Joslin. If you are applying for this Twinned Basic/Clinical award, please specify so within the "Intended Proposal",.
Awards
will be for $35,000 per year for two years,
contingent on a satisfactory progress report
after the first year.
The application process is a rather simple two-step procedure. The potential Principal Investigator should submit an electronic Intended Proposal by April 15, 2008. These proposals will be pre-reviewed for eligibility and priority, and the PIs of a number of them will be asked to electronically submit a five-page proposal by June 1st, 2008*, following an abbreviated version of a standard NIH application. These applications will be reviewed by an internal Joslin and external committee, and three P&Fs will be selected for funding to start in August.
The online
application for the P&F Intended Proposal is now CLOSED.